Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment

Wenqing Qi, Catherine Spier, Xiaobing Liu, Amit Agarwal, Laurence S. Cooke, Daniel O. Persky, Deyu Chen, Thomas P. Miller, Daruka Mahadevan

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences